$9.43 -0.13 (-1.36%)
2/10/2012 4:00 PM

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)

CAPS Rating: 3 out of 5

The Company is a clinical-stage drug development company that discovers and develops novel, small molecule drugs for the treatment of inflammatory diseases, cancer and viral diseases.

Featured Broker Partners


Advertisement